William Blair lifted their Q1 2026 earnings estimates for shares of Ionis Pharmaceuticals in a research note issued on ...
William Blair analyst Myles Minter reiterated a Buy rating on Ionis Pharmaceuticals (IONS – Research Report) today. The company’s shares opened ...
Arizona State Retirement System raised its position in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS – Free Report) by 8.8% in the ...
Ionis Pharmaceuticals (IONS) and Ono Pharmaceutical announced that the two companies have entered into a license agreement in which Ono obtains ...
LANZHOU -- A recent study has made significant progress in uncovering the microscopic mechanism behind heavy-ion cancer therapy, which is expected to optimize cancer treatment strategies and promote ...
Assembling DNA nanostructures at more moderate temperatures opens up the possibility of using the structures in biomedical ...
Researchers have confirmed that mammalian BK ion channels regulate themselves using a “ball-and-chain” mechanism. A recent ...
A new process for sustainable lithium extraction could help to address the growing global demand for the metals used in electric vehicle batteries and renewable energy storage.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results